The Successful Treatment of a Case of Linear Psoriasis with Ixekizumab
Overview
Affiliations
Linear psoriasis is an unusual clinical variation of psoriasis that manifests segmentally along the lines of Blaschko. A major differential diagnosis is inflammatory linear verrucous epidermal nevus (ILVEN). The treatment of linear psoriasis is often challenging, with inadequate response to biological agents reported in the literature. We report a case of a 25-year-old African-American female who presented with asymptomatic hyperkeratotic papules along the lines of Blaschko and was subsequently diagnosed with linear psoriasis. After failing conventional treatment regimens, the patient received a trial of ixekizumab with complete resolution of cutaneous lesions reported after 4 months and only 8 doses of the anti-IL-17 biologic agent.
Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report.
Christov S, Ohm F, Augustin M, Wagner J Psoriasis (Auckl). 2025; 15:23-28.
PMID: 39866910 PMC: 11762445. DOI: 10.2147/PTT.S499039.
Anti-tumor necrosis factor-alpha inhibitor-induced linear psoriasis: A case report.
MacIntyre O, Purdy K SAGE Open Med Case Rep. 2024; 12:2050313X241304954.
PMID: 39665032 PMC: 11632903. DOI: 10.1177/2050313X241304954.
Clinical Characteristics and Therapeutic Aspects of Blaschko Linear Psoriasis.
Chen L, Cheng Y, Peng L, Jia X, Liu G, Shen Z Dermatol Ther (Heidelb). 2024; 14(4):1039-1048.
PMID: 38578386 PMC: 11052961. DOI: 10.1007/s13555-024-01140-0.
Saifaldeen R, Fatani M, Baltow B, Khan A Case Rep Dermatol. 2018; 10(1):29-34.
PMID: 29606943 PMC: 5869485. DOI: 10.1159/000487001.